Erfan Media

Candidate Records / Nick LaLota / Medicare En español

Nick LaLota on Medicare: Lawful Immigrants Dropped From Coverage, Premium Help on Hold, and a Weaker Hospital Fund

Nick LaLota voted on July 3, 2025 for the first law that strips Medicare from people who already qualified. Refugees and asylees are among those cut off. The Congressional Budget Office counts 100,000 people losing Medicare by 2034. The same law costs Medicare $8.8 billion more for some orphan drugs.

LaLota's May 2025 vote, which the House bill needed, froze two rules on Medicare premium help. His April 2025 budget vote, also deciding, opened the way for tax cuts. Those cuts shrink a revenue stream for Medicare's hospital fund. In New York, 3,912,348 people had Medicare in 2024.

Nick LaLota's Votes on Medicare Coverage, Premium Help and the Hospital Fund

What Nick LaLota's Medicare Votes Mean for Seniors in New York

Frequently Asked Questions About Nick LaLota on Medicare

What is Nick LaLota's record on Medicare under Trump?

Nick LaLota voted for the One Big Beautiful Bill Act at both House votes, in May and July 2025. The law ends Medicare for some lawfully present immigrants. It freezes most of two rules that help poor seniors with premiums. With his deciding budget vote, he made room for tax cuts that pull money from Medicare's hospital fund.

Did Nick LaLota vote to end Medicare for refugees and asylees?

Yes. The law Nick LaLota voted for on July 3, 2025 cuts off Medicare for asylees, refugees, humanitarian parolees, Temporary Protected Status holders and several more lawfully present groups. KFF notes that people losing Medicare must keep paying Medicare payroll taxes. Under CMS's proposed rule, Social Security would send first notices from August through November 2026.

Did Nick LaLota vote to delay Medicare price talks on cancer drugs?

Yes. Nick LaLota's July 2025 vote went to a law that exempts more orphan drugs from Medicare price negotiation. KFF says the change pushes back selection of the cancer drugs Keytruda and Opdivo by at least a year. Spending on Keytruda alone, by Medicare and its patients, came to $5.6 billion in 2023. New York seniors who take these drugs keep paying the higher price longer.

Last updated: 2026-10-27

Candidate Records